(Press-News.org) A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
The study of more than 2,600 AFib patients found they are significantly more likely to develop dementia when using medicines to prevent blood clots, such as warfarin, when their dosing is too high or too low for an extended period of time.
Findings from the study will be presented at the 2014 Annual Heart Rhythm Society Scientific Session on Friday, May 9, 2014, at 6:30 pm, EDT, in San Francisco.
In the United States, nearly one in 10 people, or about 2.7 million Americans, develop AFib in their lifetimes. Atrial fibrillation is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart-related complications.
Physicians try to achieve an international normalized ratio (a test used to learn how fast the blood clots) of two to three, which is within the therapeutic range, or the safety range. Typically, dosages higher than the therapeutic range can increase the risk of bleeding. If the dose is lower than the therapeutic range, it can increase risk of blood clots forming.
Three years ago researchers at the Intermountain Medical Center Heart Institute found that patients with atrial fibrillation were at higher risk for developing dementia, but the cause of that association — the link between anticoagulation medication and dementia — was unknown.
"Most patients who develop atrial fibrillation require the use of an anticoagulant to prevent a stroke. The most common anticoagulant used worldwide is warfarin, and we now know that if warfarin doses are consistently too high or too low, one of the long-term consequences can be brain damage," said Jared Bunch, MD, lead author and director of electrophysiology research at the Intermountain Medical Center Heart Institute. "This points to the possibility that dementia in atrial fibrillation patients is partly due to small repetitive clots and/or bleeds in the brain."
Results from the Intermountain Medical Center Heart Institute study were collected from 2,693 patients, with 4.1 percent of them being diagnosed with dementia. Results were based on the percentage of time their blood-thinning medications were within the range. The more time their dosages were within the range, the less risk they had of developing dementia.
Specifically:
Patients within the therapeutic range less than 25 percent of the time were 4.5 times more likely to develop dementia.
Patients within the therapeutic range 25-50 percent of the time were 4.1 times more likely to develop dementia.
Patients within the therapeutic range 51-75 percent were only 2.5 percent more likely to develop dementia.
The increased risk remained significant when adjusting for common risks of both stroke and bleeding, noted Dr. Bunch.
"Our results from the study tell us two things," he said. "With careful use of anticoagulation medications, the dementia risk can be reduced. Patients on warfarin need very close follow-up in specialized anticoagulation centers if possible to ensure their blood levels are within the recommended levels more often.
"Second, these results also point to a potential new long-term consequence of dependency on long-term anticoagulation medications. In this regard, stroke prevention therapies do not require long-term anticoagulation medications and reducing the use of these drugs will hopefully lower dementia risk."
Dementia is cognitive dysfunction that impacts quality of life. Dementia is a progressive disease, and the impact on quality of life often worsens not only for patients, but also for their families and loved ones.
Warfarin is used to prevent blood clots in atrial fibrillation patients, and though it is an effective therapy, the drug poses risks if improperly dosed. Proper dosing of warfarin is complicated because the drug interacts with many other common medications, as well as some foods.
When determining an initial dose of warfarin, physicians often start with a standard dose and can take certain clinical indicators into account to alter that dose. These clinical measures include age, body size, smoking status, and use of certain medications. During the initial weeks of therapy, the warfarin activity is monitored closely through blood tests, and adjustments are made as needed.
INFORMATION: END
Study finds patients AFib at higher risk of dementia when meds out of range
Study included 2,600 AFib patients
2014-05-10
ELSE PRESS RELEASES FROM THIS DATE:
Bee biodiversity boosts crop yields
2014-05-10
Research from North Carolina State University shows that blueberries produce more seeds and larger berries if they are visited by more diverse bee species, allowing farmers to harvest significantly more pounds of fruit per acre.
"We wanted to understand the functional role of diversity," says Dr. Hannah Burrack, an associate professor of entomology at NC State and co-author of a paper on the research. "And we found that there is a quantifiable benefit of having a lot of different types of bees pollinating a crop."
The researchers looked at blueberries in North Carolina ...
Scientists find gene behind a highly prevalent facial anomaly
2014-05-10
CAMBRIDGE, Mass. (May 9, 2014) – Whitehead Institute scientists have identified a genetic cause of a facial disorder known as hemifacial microsomia (HFM). The researchers find that duplication of the gene OTX2 induces HFM, the second-most common facial anomaly after cleft lip and palate.
HFM affects approximately one in 3,500 births. While some cases appear to run in families, no gene had been found to be causative. That is until Whitehead Fellow Yaniv Erlich and his lab set out to do just that. Their work is described in this week's issue of the journal PLOS ONE.
Patients ...
Cardiac screening test may help determine who should take aspirin to prevent heart attack
2014-05-09
MINNEAPOLIS, MN – May 6, 2014 – For over 30 years, aspirin has been known to prevent heart attacks and strokes, but who exactly should take a daily aspirin remains unclear. New research published today in Circulation: Cardiovascular Quality and Outcomes shows that your coronary artery calcium (CAC) score, a measurement of plaque in the arteries that feed the heart, may help determine whether or not you are a good candidate for aspirin.
"Many heart attacks and strokes occur in individuals who do not appear to be at high risk," states lead author, Michael D Miedema, MD, ...
NASA's TRMM Satellite see spring storms hit the US Great Plains
2014-05-09
VIDEO:
The TRMM satellite flew above tornado spawning thunderstorms in the southern United States on May 9, 2014 at 0115 UTC. This simulated 3-D TRMM animation shows the location of intense...
Click here for more information.
The Tropical Rainfall Measuring Mission or TRMM satellite captured rainfall and cloud height information about the powerful thunderstorms and severe weather that affected the Great Plains over May 8 and 9.
Severe weather extended from Minnesota to southern ...
Plugging leaky blood vessels to save vision
2014-05-09
TORONTO – A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto.
The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with premature birth, with diabetes, and with increasing age.
Research just published by Dr. Andras Nagy and co-authors shows both safety and effectiveness in their bioengineered compound when treating retinopathy ...
Paleontologists discover new fossil organism
2014-05-09
RIVERSIDE, Calif. — Scientists at the University of California, Riverside have discovered a fossil of a newly discovered organism from the "Ediacara Biota" — a group of organisms that occurred in the Ediacaran period of geologic time.
Named Plexus ricei and resembling a curving tube, the organism resided on the Ediacaran seafloor. Plexus ricei individuals ranged in size from 5 to 80 centimeters long and 5 to 20 millimeters wide. Along with the rest of the Ediacara Biota, it evolved around 575 million years ago and disappeared from the fossil record around 540 million ...
Discovery links rare, childhood neurodegenerative diseases to common problem in DNA repair
2014-05-09
(MEMPHIS, Tenn. – May 9, 2014) St. Jude Children's Research Hospital scientists studying two rare, inherited childhood neurodegenerative disorders have identified a new, possibly common source of DNA damage that may play a role in other neurodegenerative diseases, cancer and aging. The findings appear in the current issue of the scientific journal Nature Neuroscience.
Researchers showed for the first time that an enzyme required for normal DNA functioning causes DNA damage in the developing brain. DNA is the molecule found in nearly every cell that carries the instructions ...
Longevity gene may boost brain power
2014-05-09
Scientists showed that people who have a variant of a longevity gene, called KLOTHO, have improved brain skills such as thinking, learning and memory regardless of their age, sex, or whether they have a genetic risk factor for Alzheimer's disease. Increasing KLOTHO gene levels in mice made them smarter, possibly by increasing the strength of connections between nerve cells in the brain. The study was partly funded by the National Institutes of Health.
"This could be a major step toward helping millions around the world who are suffering from Alzheimer's disease and ...
Autism-related protein shown to play vital role in addiction
2014-05-09
BELMONT - In a paper published in the latest issue of the neuroscience journal Neuron, McLean Hospital investigators report that a gene essential for normal brain development, and previously linked to Autism Spectrum Disorders, also plays a critical role in addiction-related behaviors.
"In our lab, we investigate the brain mechanisms behind drug addiction – a common and devastating disease with limited treatment options," explained Christopher Cowan, PhD, director of the Integrated Neurobiology Laboratory at McLean and an associate professor of Psychiatry at Harvard Medical ...
Quick test can help spot depressed teenagers, UT Arlington nursing researcher finds
2014-05-09
A few minutes spent filling out a widely accepted mental health assessment in a health care provider's waiting room could make a big difference for some teenagers suffering from depression, according to new study from a nursing researcher at The University of Texas at Arlington.
Sharolyn Dihigo, a nurse practitioner and clinical assistant professor in the UT Arlington College of Nursing, recently examined available research to determine whether nurse practitioners and others in primary care settings should add a mental health screening to well visits for teenage patients. ...
LAST 30 PRESS RELEASES:
Being physically active, even just a couple of days a week, may be key to better health
High-fat diet promote breast cancer metastasis in animal models
A router for photons
Nurses and AI collaborate to save lives, reduce hospital stays
Multi-resistance in bacteria predicted by AI model
Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection
Sensing sickness
Cost to build multifamily housing in California more than twice as high as in Texas
Program takes aim at drinking, unsafe sex, and sexual assault on college campuses
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
[Press-News.org] Study finds patients AFib at higher risk of dementia when meds out of rangeStudy included 2,600 AFib patients